dQ&A is announcing upcoming data releases for our flagship products: Prescriber Perspectives (Europe) and Patient Voice (Europe).
dQ&A helps clients include robust patient-preference studies in FDA regulatory submissions, strengthening decisions that shape diabetes care.
dQ&A launches a new tracking study of Italians with type 1 and type 2 diabetes, capturing real-world insights on care, technology use, and daily challenges.
dQ&A was honored to participate in the 2019 ADA Scientific Sessions with five posters and an abstract highlighting our work.
Our study reveals that perceptions of hypoglycemia profoundly shape life with diabetes, exposing its broad mental, emotional, and physical toll.
It’s important to be sure you have high-quality answers before making important clinical or commercial decisions.
Our research reveals how diabetes-friendly grocery stores really are, uncovering key barriers and ways to improve the shopping experience.
A 3,000-person dQ&A survey shows 9% of those with T1D and 17% of those with T2D on insulin reported that they have self-rationed insulin because of cost.
Our research found that diabetes keeps many awake at night due to symptoms, complications, and comorbidities of diabetes.
